{"id":651622,"date":"2023-05-16T15:34:01","date_gmt":"2023-05-16T15:34:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=651622"},"modified":"2023-05-16T15:34:01","modified_gmt":"2023-05-16T15:34:01","slug":"chronic-refractory-gout-crg-market-size-and-share-trends-epidemiology-and-market-forecast-report-2032-companies-ampel-biosolutions-selecta-biosciences","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/chronic-refractory-gout-crg-market-size-and-share-trends-epidemiology-and-market-forecast-report-2032-companies-ampel-biosolutions-selecta-biosciences_651622.html","title":{"rendered":"Chronic Refractory Gout (CRG) Market Size and Share, Trends, Epidemiology and Market Forecast Report 2032 | Companies &#8211; Ampel BioSolutions, Selecta Biosciences"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1684217015.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Chronic Refractory Gout (CRG) Market Size and Share, Trends, Epidemiology and Market Forecast Report 2032 | Companies - Ampel BioSolutions, Selecta Biosciences\" src=\"https:\/\/www.abnewswire.com\/uploads\/1684217015.jpeg\" alt=\"Chronic Refractory Gout (CRG) Market Size and Share, Trends, Epidemiology and Market Forecast Report 2032 | Companies - Ampel BioSolutions, Selecta Biosciences\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Chronic Refractory Gout Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u201d Chronic Refractory Gout (CRG) \u2013 Market Insights, Epidemiology, and Market Forecast-2032\u2033 report delivers an in-depth understanding of the Chronic Refractory Gout (CRG), historical and forecasted epidemiology as well as the Chronic Refractory Gout (CRG) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>DelveInsight has launched a new report on &#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-refractory-gout-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Chronic Refractory Gout (CRG) &#8211; Market Insights, Epidemiology, and Market Forecast-2032<\/a>.<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &rdquo; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-refractory-gout-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Chronic Refractory Gout (CRG) &ndash; Market Insights, Epidemiology, and Market Forecast-2032<\/a>&Prime; report delivers an in-depth understanding of the Chronic Refractory Gout (CRG), historical and forecasted epidemiology as well as the Chronic Refractory Gout (CRG) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Chronic Refractory Gout Market Report:&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">1. According to the article, prevalence of gout in the UK, Germany, Canada, US, and New Zealand has varied from 1.4% to 3.9%.<\/p>\n<p style=\"text-align: justify;\">2. According to a study the prevalence of gout rose by 63.9% between 1997\u20122012.<\/p>\n<p style=\"text-align: justify;\">3. According to a study, Chronic gout that is refractory to conventional urate lowering therapy with a high burden of symptoms, such as frequent flares and tophi, is estimated to occur in approximately 25,000&ndash;100,0001 of the 3&ndash;6 million Americans who suffer from gout.<\/p>\n<p style=\"text-align: justify;\"><strong>Key benefits of the Chronic Refractory Gout Market report:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Chronic Refractory Gout (CRG) market report covers a descriptive overview and comprehensive insight of the Chronic Refractory Gout (CRG) epidemiology and Chronic Refractory Gout (CRG) market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/p>\n<p style=\"text-align: justify;\">2. Chronic Refractory Gout (CRG) market report provides insights on the current and emerging therapies.<\/p>\n<p style=\"text-align: justify;\">3. Chronic Refractory Gout (CRG) market report provides a global historical and forecasted market covering drug outreach in 7 MM.<\/p>\n<p style=\"text-align: justify;\">4. Chronic Refractory Gout (CRG) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Chronic Refractory Gout (CRG) market.<\/p>\n<p style=\"text-align: justify;\"><strong>Request for sample pages: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/chronic-refractory-gout-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">https:\/\/www.delveinsight.com\/sample-request\/chronic-refractory-gout-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Chronic Refractory Gout (CRG): Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Inflammatory arthritis caused by the deposition of monosodium urate (MSU) crystals in synovial fluid and other tissues.<\/p>\n<ol style=\"text-align: justify;\">\n<li>Crystal deposition occurs when serum uric acid (SUA) concentration exceeds its solubility&nbsp;<\/li>\n<li>As gout progresses, crystal deposition can occur anywhere in the body<\/li>\n<li>Chronic disease can lead to sequelae including:<\/li>\n<\/ol>\n<ul style=\"text-align: justify;\">\n<li>Bone erosions&nbsp;<\/li>\n<li>Tophi<\/li>\n<li>&nbsp;Chronic pain&nbsp;<\/li>\n<li>Joint deformities<\/li>\n<li>&nbsp;Loss of function<\/li>\n<li>&nbsp;Disability&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>The key players involved in <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-refractory-gout-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Chronic Refractory Gout (CRG) market<\/a> are:<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li>Ampel BioSolutions<\/li>\n<li>Selecta Biosciences<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>The launch of the emerging therapies is expected to significantly impact the Chronic Refractory Gout (CRG) treatment scenario in the upcoming years:-<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Drugs covered<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li>Azathioprine<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Request a free sample report @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/chronic-refractory-gout-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">https:\/\/www.delveinsight.com\/sample-request\/chronic-refractory-gout-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Chronic Refractory Gout (CRG) Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Chronic Refractory Gout (CRG) Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Chronic Refractory Gout (CRG) Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Chronic Refractory Gout (CRG) Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Chronic Refractory Gout (CRG)<\/p>\n<p style=\"text-align: justify;\">9. Chronic Refractory Gout (CRG) Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Chronic Refractory Gout (CRG) Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Chronic Refractory Gout (CRG) Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Chronic Refractory Gout (CRG) Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Chronic Refractory Gout (CRG) Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=chronic-refractory-gout-crg-market-size-and-share-trends-epidemiology-and-market-forecast-report-2032-companies-ampel-biosolutions-selecta-biosciences\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=chronic-refractory-gout-crg-market-size-and-share-trends-epidemiology-and-market-forecast-report-2032-companies-ampel-biosolutions-selecta-biosciences\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chronic Refractory Gout Market DelveInsight\u2019s \u201d Chronic Refractory Gout (CRG) \u2013 Market Insights, Epidemiology, and Market Forecast-2032\u2033 report delivers an in-depth understanding of the Chronic Refractory Gout (CRG), historical and forecasted epidemiology as well as the Chronic Refractory Gout (CRG) &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/chronic-refractory-gout-crg-market-size-and-share-trends-epidemiology-and-market-forecast-report-2032-companies-ampel-biosolutions-selecta-biosciences_651622.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-651622","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/651622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=651622"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/651622\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=651622"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=651622"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=651622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}